A recent review of astaxanthin found evidence to support the safety of dosages of 12 mg up to 24 mg a day. But that applies to only to natural astaxanthin, not to the synthetic forms, the authors said.
Higher blood levels of omega-3 are not associated with an increased risk of prostate cancer, according to new data published last week at the 2019 American Heart Association Scientific Sessions in Philadelphia.
An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.
Growing consumer awareness along with demand in animal nutrition is driving the overall growth of prebiotics, which a trade group says will account for $5.5 billion in sales in 2019. Better messaging can help maintain that momentum, the group says.
A database that includes 4,000-plus clinical trials on EPA and DHA omega-3s will help companies with claims substantiation, and provide ready access to significant scientific data to counter negative consumer media articles, says GOED’s executive director.